Consumption of sweetened, dried cranberries may reduce urinary tract infection incidence in susceptible women – a modified observational study

Nutrition Journal

Walter J Hopkins⁴  Christian G Krueger³  Jess D Reed³  Sarah E McAchran⁴  Susan M Benck¹  Alexandra E Burleigh² 

[1] Department of Urology, University of Wisconsin Hospital and Clinics, 600 Highland Avenue, Madison, WI 53792, USA;Department of Urology, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, Madison, WI 53792, USA;Department of Nutritional Sciences, University of Wisconsin-Madison, 256 Animal Science Bldg, 1675 Observatory Drive, Madison, WI 53706, USA;Department of Urology, University of Wisconsin School of Medicine and Public Health, 1685 Highland Ave, Madison, WI 53705, USA

关键词: Prevention;    E. coli;    Recurrent;    Cranberry;    Urinary tract infection;   

Others  :  803320
DOI  :  10.1186/1475-2891-12-139

 received in 2013-05-05, accepted in 2013-10-02,  发布年份 2013

【 摘 要 】

Background

Urinary tract infections (UTIs) are one of the most common bacterial infections, and over 50% of women will have a UTI during their lifetimes. Antibiotics are used for prophylaxis of recurrent UTIs but can lead to emergence of drug-resistant bacteria. Therefore, it is reasonable to investigate nutritional strategies for prevention of UTIs. Cranberry juices and supplements have been used for UTI prophylaxis, but with variable efficacy. Because dried cranberries may contain a different spectrum of polyphenolics than juice, consuming berries may or may not be more beneficial than juice in decreasing the incidence of UTIs in susceptible women. The primary objectives of this study were to determine if consumption of sweetened, dried cranberries (SDC) decreases recurrent UTIs and whether this intervention would alter the heterogeneity, virulence factor (VF) profiles, or numbers of intestinal E. coli.

Methods

Twenty women with recurrent UTIs were enrolled in the trial and consumed one serving of SDC daily for two weeks. Clinical efficacy was determined by two criteria, a decrease in the six-month UTI rates pre- and post-consumption and increased time until the first UTI since beginning the study. Strain heterogeneity and virulence factor profiles of intestinal E. coli isolated from rectal swabs were determined by DNA fingerprinting and muliplex PCR, respectively. The numbers of intestinal E. coli eluted from rectal swabs pre- and post-consumption were also quantified.

Results

Over one-half of the patients did not experience a UTI within six months of SDC consumption, and the mean UTI rate per six months decreased significantly. Kaplan-Meier analysis of infection incidence in women consuming SDC compared to patients in a previous control group showed a significant reduction in time until first UTI within six months. The heterogeneity, VF profiles, and prevalence of intestinal E. coli strains were not significantly different after cranberry consumption.

Conclusions

Results of this study indicate a beneficial effect from consuming SDC to reduce the number of UTIs in susceptible women. Because there were no changes in the heterogeneity or VF profiles of E. coli, additional studies are needed to determine the mechanism of action of SDC for reduction of UTIs.

【 授权许可】

   
2013 Burleigh et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Fihn SD: Acute uncomplicated urinary tract infection in women. N Engl J Med 2003, 349:259-266.
• [2]Griebling TL: Urologic diseases in America project: trends in resource use for urinary tract infections in women. J Urol 2005, 173:1281-1287.
• [3]Foxman B: Recurrent urinary tract infections: incidence and risk factors. Am J Public Health 1990, 80:331-333.
• [4]Albert X, Huertas I, Pereiro II, et al.: Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev 2004., 3CD001209
• [5]Gupta K, Hooton TM, Naber KG, et al.: International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: 2010 update by the infectious diseases society of America and the European society for microbiology and infectious diseases. Clin Infect Dis 2011, 52(5):e103-e120.
• [6]Melekos MD, Asbach HW, Gerharz E, et al.: Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women. J Urol 1997, 157:935-939.
• [7]Goemaere N, Grijm K, van Hal P, et al.: Nitrofurantoin induced pulmonary fibrosis: a case report. J Med Case Reports 2008, 2:169-173. BioMed Central Full Text
• [8]Nosseir SB, Lind LR, Winkler HA: Recurrent uncomplicated urinary tract infections in women: a review. J Womens Health 2012, 21:347-354.
• [9]Kontiokari T, Sundqvist K, Nuutinen M, et al.: Randomised trial of cranberry–lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 2001, 322:1571.
• [10]Jepson JP, Craig JC: Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2008., 1CD001321
• [11]Barbosa-Cesnik C, Brown MB, Buxton M, et al.: Cranberry juice fails to prevent recurrent urinary tract infection: results from a randomized placebo controlled trial. Clin Infect Dis 2011, 52:23-30.
• [12]Howell AB, Botto H, Combescure C, et al.: Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study. BMC Infect Dis 2010, 10:94. BioMed Central Full Text
• [13]Johnson JR, Russo TA, Brown JJ, et al.: PapG alleles of Escherichia coli strains causing first-episode or recurrent acute cystitis in adult women. J Infect Dis 1998, 177:97-101.
• [14]Foxman B: Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002, 113:5-13.
• [15]Kaper JB, Nataro JP, Mobley HL: Pathogenic Escherichia coli. Nat Rev Microbiol 2004, 2:123-140.
• [16]Kullback S, Leibler RA: On information and sufficiency. Ann Math Stat 1951, 22:79-86.
• [17]Lidin-Janson G, Kaijser B, Lincoln K, et al.: The homogeneity of the faecal coliform flora of normal school-girls, characterized by serological and biochemical properties. Med Microbiol Immunol 1978, 164:247-253.
• [18]Versalovic J, Schneider M, DeBrujin FJ, et al.: Genomic fingerprinting of bacteria using repetitive sequence-based polymerase chain reactions. Methods Mol Cel Biol 1994, 5:25-40.
• [19]McDaniels AE, Rice EW, Reyes AL, et al.: Confirmation Identification of Escherichia coli, a comparison of genotypic and phenotypic assays for glutamate decarboxylase and beta-D-glucuronidase. Appl Environ Microbiol 1996, 62:3350-3354.
• [20]Johnson JR, Stell AL: Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000, 181:261-272.
• [21]Vigil PD, Stapleton AE, Johnson JR, et al.: Presence of putative repeat-in-toxin gene tosA in Escherichia coli predicts successful colonization of the urinary tract. mBio 2011, 2(3):e00066. 11
• [22]Clermont O, Bonacorsi S, Bingen E: Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Mircrobiol 2000, 66:4555-4558.
• [23]Sabaté M, Moreno E, Pérez E, et al.: Pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates. Clin Microbiol Infect 2006, 12:880-886.
• [24]Hopkins WJ, Elkahwaji JE, Beierle LM, et al.: Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial. J Urol 2007, 177:1349-1353.
• [25]Amalaradjou MAR, Narayanan A, Venkitanarayanan K: Trans-cinnamaldehyde decreases attachment and invasion of uropathogenic Escherichia coli in urinary tract epithelial cells by modulating virulence gene expression. J Urol 2011, 185:1526-1531.
• [26]Brackman G, Defoirdt T, Miyamoto C, et al.: Cinnamaldehyde and cinnamaldehyde derivatives reduce virulence in vibrio spp. By decreasing the DNA-binding activity of the quorum sensing response regulator LuxR. BMC Microbiol 2008, 8:149. BioMed Central Full Text
• [27]Hidalgo G, Chan M, Tufenkji N: Inhibition of Escherichia coli CFT073 fliC expression and motility by cranberry materials. App Environ Microbiol 2011, 77:6852-6857.
• [28]Wang W-B, Lai H-C, Hsueh P-R, et al.: Inhibition of swarming and virulence factor expression in Proteus mirabilis by resveratrol. J Med Microbiol 2006, 55:1313-1321.
• [29]Pierre JF, Heneghan AF, Feliciano RP, et al.: Cranberry proanthocyanidins improve intestinal sIgA during elemental enteral nutrition. JPEN J Parenter Enteral Nutr 2013. Epub ahead of print
• [30]Nantz MP, Rowe CA, Muller CE, et al.: Cranberry phytochemicals modify human immune function and appear to reduce the severity of cold and flu symptoms. FASEB J 2010, 24:326.6.